LeeAnn Levesque
Public Communications Contact presso ANALOGIC CORPORATION
Profilo
LeeAnn Levesque is currently the Chief Diversity Officer & VP-Business Development at Analogic Corp.
and the Chief Diversity Officer at Lundbeck Seattle BioPharmaceuticals, Inc. She previously served as the Chief Executive Officer at SureScan Corp.
Posizioni attive di LeeAnn Levesque
| Società | Posizione | Inizio |
|---|---|---|
| ANALOGIC CORPORATION | Public Communications Contact | - |
| ALDER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Precedenti posizioni note di LeeAnn Levesque
| Società | Posizione | Fine |
|---|---|---|
SureScan Corp.
 SureScan Corp. Aerospace & DefenseElectronic Technology SureScan Corp. manufactures security scanning devices. It offers x1000 TSA Certified and ECAC EDS Std 3 system, designed for high speed screening of baggage and packages. The company was founded on May 10, 2004 and is headquartered in Endicott, NY. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Analogic Corp.
 Analogic Corp. Medical SpecialtiesHealth Technology Analogic Corp. engages in the business of designing, development manufacturing, and supporting technically advanced and cost-effective imaging and detection, and power and automation solutions for security, healthcare, and other high-end industrial markets. The firm is also involved in the innovation in the field of computed tomography. The company was founded by Bernard Marshall Gordon on November 27, 1967 and is headquartered in Peabody, MA. | Health Technology |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
SureScan Corp.
SureScan Corp. Aerospace & DefenseElectronic Technology SureScan Corp. manufactures security scanning devices. It offers x1000 TSA Certified and ECAC EDS Std 3 system, designed for high speed screening of baggage and packages. The company was founded on May 10, 2004 and is headquartered in Endicott, NY. | Electronic Technology |
- Borsa valori
- Insiders
- LeeAnn Levesque
